Cetuximab versus methotrexate in first-line treatment of older, frail patients with inoperable recurrent or metastatic head and neck cancer (ELAN UNFIT): a randomised, open-label, phase 3 trial
Resource Type
Article
Authors
Guigay, Joël ; Ortholan, Cécile ; Vansteene, Damien ; Cupissol, Didier ; Even, Caroline ; Kaminsky, Marie-Christine ; Sire, Christian ; Blot, Emmanuel ; Debourdeau, Philippe ; Bozec, Laurence ; Saada-Bouzid, Esma ; Fayette, Jérôme ; Dalloz, Pierre ; Pointreau, Yoann ; Caer, Hervé Le ; Falandry, Claire ; Digue, Laurence ; Braccini, Antoine ; Lopez, Stéphane ; Guillet, Pierre ; Michel, Cécile ; Cheurfa, Nadir ; Schwob, Dominique ; Bourhis, Jean ; Mertens, Cécile ; Aupérin, Anne
Source
In The Lancet Healthy Longevity March 2024 5(3):e182-e193
Subject
Primary Research Articles
Language
ISSN
2666-7568